Company Filing History:
Years Active: 2018
Title: Rencia Van Der Sluis: Innovator in Recombinant Enzyme Technology
Introduction
Rencia Van Der Sluis is a notable inventor based in Potchefstroom, South Africa. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant enzymes. His work has implications for therapeutic applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Rencia holds a patent for a method of producing recombinant glycine N-acyltransferase. This invention relates to a process that includes providing a suitable expression host, preparing a vector with a gene for expressing GLYAT, transforming the host with the expression plasmid, expressing the GLYAT gene, and separating the expressed enzyme from the expression system. This patent highlights his expertise in enzyme production and its potential therapeutic uses. He has 1 patent to his name.
Career Highlights
Rencia is affiliated with Northwest University, where he engages in research and development in the field of biotechnology. His academic background and professional experience have positioned him as a key figure in enzyme research. His innovative approach has led to advancements in the production of therapeutic enzymes.
Collaborations
Rencia has collaborated with notable colleagues, including Lodewyk Jacobus Mienie and Alberdina Aike Van Dijk. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their field.
Conclusion
Rencia Van Der Sluis exemplifies the spirit of innovation in biotechnology through his work on recombinant enzymes. His contributions not only advance scientific knowledge but also hold promise for therapeutic applications.